
Subsidiary5 Nov 2026, 01:08 pm
Fermenta Biotech to close UK subsidiary
AI Summary
Fermenta Biotech Ltd's Board of Directors has approved the closure of its wholly-owned subsidiary, Fermenta Biotech (UK) Limited (FBL UK). The closure is attributed to various reasons including Brexit and the presence of an operational subsidiary in Germany to serve the European market. FBL UK has had no operations for several years, with zero turnover and a loss of £1,260 in FY 2025-26, and net assets of £30,231 primarily in cash. The decision aims to streamline corporate structure and reduce compliance costs. FBL UK is not considered a material subsidiary.
Key Highlights
- Board approves closure of UK subsidiary, Fermenta Biotech (UK) Limited.
- Subsidiary has had no operations for several years.
- Closure aims to reorganize corporate structure and cut costs.
- FBL UK is not a material subsidiary to Fermenta Biotech.
- Financials show minimal loss and cash assets for FBL UK.
Price Impact
More from FERMENTA